CAS Number33419-42-0
SynonymsVP-16-213; 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-β-D-glucopyranoside); Vepeside; 4'-Demethylepipodophyllotoxin ethylidene-β-D-glucoside; EPEG; MFCD00869325; 4′-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-β-D-glucopyranoside); 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-β-D-glucopyranoside); EINECS 251-509-1
Molecular FormulaC29H32O13
Molecular Weight588.56
Purity95.0-105.0%
Density1.6±0.1 g/cm3
Boiling Point798.1±60.0 °C at 760 mmHg
Melting Point236-251 °C (lit.)
Appearancepowder
EINECS251-509-1
Symbol
Signal WordWarning
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 33419-42-0 |
| Catalog No. | 2A-9010424 |
| Chinese Name | 依托泊苷 |
| Synonyms | VP-16-213; 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-β-D-glucopyranoside); Vepeside; 4'-Demethylepipodophyllotoxin ethylidene-β-D-glucoside; EPEG; MFCD00869325; 4′-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-β-D-glucopyranoside); 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-β-D-glucopyranoside); EINECS 251-509-1 |
| Molecular Formula | C29H32O13 |
| Molecular Weight | 588.56 |
| Purity | 95.0-105.0 |
| Density | 1.6±0.1 g/cm3 |
| Boiling Point | 798.1±60.0 °C at 760 mmHg |
| Melting Point | 236-251 °C (lit.) |
| Appearance | powder |
| Water Solubility | Water solubility: Practically insoluble; Easily so |
| Storage Condition | Keep the receptacle sealed, stored in a cool, dry |
| Packaging | II |
| Application | Etoposide is a chemotherapy drug used to treat a variety of cancers. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. |
| EINECS | 251-509-1 |
| HTC | 2932999099 |
| PubChem ID | 24278178 |
| MDL Number | MFCD00869325 |
| SMILES | COc1cc(cc(OC)c1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)c6cc7OCOc7cc26 |
| InChI | 1S/C29H32O13/c1-11-36-9-20-27(40-11)24(31)25(32)29(41-20)42-26-14-7-17-16(38-10-39-17)6-13(14)21(22-15(26)8-37-28(22)33)12-4-18(34-2)23(30)19(5-12)35-3/h4-7,11,15,20-22,24-27,29-32H,8-10H2,1-3H3/t11-,15+,20-,21-,22+,24-,25-,26-,27-,29+/m1/s1 |
| InChI Key | VJJPUSNTGOMMGY-MRVIYFEKSA-N |
| NACRES Code | NA.77 |
| UNSPSC | 12352200 |
| Hazard Symbols | 6.1(a) |
| MSDS | msds/10424_1_33419_42_0.pdf |
| Bioactivity | Etoposide is a chemotherapy medication used for the treatments of a number of types of cancer. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. Related Catalog Signaling Pathways >> Autophagy >> Autophagy Signaling Pathways >> Autophagy >> Mitophagy Signaling Pathways >> Cell Cycle/DNA Damage >> Topoisomerase Research Areas >> Cancer Target Topoisomerase II In Vitro Etoposide is capable of causing cytotoxicity on pancreatic β-cells by inducing apoptosis through the JNK/ERK-mediated GSK-3 downstream-triggered mitochondria-dependent signaling pathway in RIN-m5F cells[1]. Etoposide and Bevacizumab significantly abolish P1 sphere-forming ability, an effect associated with apoptosis of this subset of cells[2]. In Vivo Etoposide (50 μM) and Bevacizumab-treated hypoxic cells injected intravenously into immunodeficient mice reveals a reduced capacity to induce lung colonies, which also appear with a longer latency period[2]. Etoposide (10 mg/kg/day, i.v.) with ifosfamide and carboplatin, reduces the tumor volume in the hepatoblastoma cell injected NMRI nude mice[3]. Kinase Assay RIN-m5F cells are seeded and treated with Etoposide (10-50 μM) in the absence or presence of Z-DEVD-FMK (20 μM). At the end of treatments (for 24 h), the cell lysates are incubated at 37°C with 10 μM Ac-DEVD-AMC, a caspase-3/CPP32 substrate, for 1 h. The fluorescence of the cleaved substrate is measured by a spectrofluorometer with an excitation wavelength at 380 nm and an emission wavelength at 460 nm. Protein levels of cell lysate samples are determined using the bicinchoninic acid protein assay kit with an absorption band of 570 nm to normalize the cell numbers between control and etoposide-treated groups. Cell Assay RIN-m5F cell is a rat pancreatic β-cell line, and cultured in a humidified chamber with a 5% CO2-95% air mixture at 37°C and maintained in RPIM 1640 medium supplemented with 10% fetal bovine serum (FBS) and antibiotics (100 U/mL of penicillin and 100 μg/mL of streptomycin). RIN-m5F cells are seeded (2 × 104 cells/well) in 96-well plates and allowed to adhere and recover overnight. The cells are changed to fresh media and then incubated with Etoposide (1-100 μM) in the absence or presence of the pharmacological inhibitors (lithium chloride (LiCl)-50 μM; SP600125-20 μM; PD98059-20 μM) for 24 h. Animal Admin The in vivo model for nude mice HB (NMHB) has been established. Only HB cells with embryonal components are grafted and reproduced successfully in this model. Each NMHB subsequently is transplanted into 50 mice for treatment groups. Treatment is initiated when the majority of the tumors reach a volume of 50-100 mm3. The mice are stratified according to their tumor volume and randomLy assigned to groups of ten animals each. The animals injected with tumor are given ifosfamide, cisplatin, doxorubicin, etoposide (10 mg/kg/day, i.v.), and carboplatin as single agents in two blocks. One group of ten animals for each original xenograft served as a control group. After initiation of treatment, the tumor growth is recorded at 5-day intervals for 25-30 days and the relative tumor volumes are calculated. Twenty-four hours before the animals are sacrificed, bromodeoxyuridine (BrdU) is injected intraperitoneally for the semiquantitative determination of proliferation activity of the tumor cells (50 μg of BrdU/g body weight). References [1]. Lee KI, et al. Etoposide induces pancreatic β-cells cytotoxicity via the JNK/ERK/GSK-3 signaling-mediated mitochondria-dependent apoptosis pathway. Toxicol In Vitro. 2016 Jul 26. pii: S0887-2333(16)30147-3. [2]. Calvani M, det al. Etoposide-Bevacizumab a new strategy against human melanoma cells expressing stem-like traits. Oncotarget. 2016 Jun 9. doi: 10.18632/oncotarget.9939. [3]. Fuchs, J., et al. Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma. Cancer, 1998. 83(11): p. 2400-7. Chemical & Physical Properties Density 1.6±0.1 g/cm3 Boiling Point 798.1±60.0 °C at 760 mmHg Melting Point 236-251ºC Molecular Formula C29H32O13 Molecular Weight 588.557 Flash Point 263.6±26.4 °C Exact Mass 588.184265 PSA 160.83000 LogP 0.30 Vapour Pressure 0.0±3.0 mmHg at 25°C Index of Refraction 1.662 InChIKey VJJPUSNTGOMMGY-NBJJDLTASA-N SMILES COc1cc(C2c3cc4c(cc3C(OC3OC5COC(C)OC5C(O)C3O)C3COC(=O)C23)OCO4)cc(OC)c1O |
| Use of | Etoposide is a chemotherapy medication used for the treatments of a number of types of cancer. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. Properties Articles411 Name etoposide Synonym More Synonyms Etoposide Biological Activity Description Etoposide is a chemotherapy medication used for the treatments of a number of types of cancer. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. Related Catalog Signaling Pathways >> Autophagy >> Autophagy Signaling Pathways >> Autophagy >> Mitophagy Signaling Pathways >> Cell Cycle/DNA Damage >> Topoisomerase Research Areas >> Cancer Topoisomerase II In Vitro Etoposide is capable of causing cytotoxicity on pancreatic β-cells by inducing apoptosis through the JNK/ERK-mediated GSK-3 downstream-triggered mitochondria-dependent signaling pathway in RIN-m5F cells[1]. Etoposide and Bevacizumab significantly abolish P1 sphere-forming ability, an effect associated with apoptosis of this subset of cells[2]. References [1]. Lee KI, et al. Etoposide induces pancreatic β-cells cytotoxicity via the JNK/ERK/GSK-3 signaling-mediated mitochondria-dependent apoptosis pathway. Toxicol In Vitro. 2016 Jul 26. pii: S0887-2333(16)30147-3. [3]. Fuchs, J., et al. Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma. Cancer, 1998. 83(11): p. 2400-7. Chemical & Physical Properties Molecular Formula C29H32O13 Exact Mass 588.184265 PSA 160.83000 Index of Refraction 1.662 InChIKey VJJPUSNTGOMMGY-NBJJDLTASA-N |
| Tax Rebate | 13.0% |
| Supervision | None. MFN tariff: 6.5%. Ordinary tariff: 20.0% |
| Transport Info | Shipping Name: UN |
| MSDS Transport Info | Module 14. Shipping information 14.1 UN dangerous goods number European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.2 United Nations shipping name European Land Transport Dangerous Regulations: Non-dangerous goods IMDG Code: Non-dangerous goods International air transport dangerous goods regulations: non-dangerous goods 14.3 Transport hazard categories European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.4 Package group European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.5 Environmental hazards European Land Transport Danger Regulations: No International Maritime Danger Regulations International Air Transport Danger Regulations: No Marine pollutants (yes/no): No 14.6 Special reminder to users No data available |
| Related Products in API & Advanced Intermediates | ||
|---|---|---|
| Erythromycin thiocyanate | 7704-67-8 | 2A-9010374 |
| Escitalopram | 128196-01-0 | 2A-0202054 |
| Estriol | 50-27-1 | 2A-9010388 |
| Ethambutol | 74-55-5 | 2A-9010395 |
| Ethylmorphine | 76-58-4 | 2A-9010408 |
| Etoposide phosphate | 117091-64-2 | 2A-9010425 |
| Etoricoxib | 202409-33-4 | 2A-9010426 |
| Exemestane | 107868-30-4 | 2A-9010439 |
| Febuxostat | 144060-53-7 | 2A-9010455 |
| Felodipine HCL | 72509-76-3 | 2A-9010457 |
| Browse all API & Advanced Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS